Principal Scientist, Pharm Sci Small Molecules
CurrentSubject matter expert in all areas of bioassay development with focus on immunogenicity and product safety.• Isolation, depletion, and differentiation of cell types from PBMC populations for immunogenicity testing.• PBMC proliferation assay development and immunogenicity testing of drug products and product impurities to establish product safety.• Development of assay to measure risk of adverse drug reactions using KU812F cells and B-hexosaminidase that enabled the risk assessment of drug candidates.• Preparation, performance assessment, and mycoplasma testing of cell banks for use in bioassays and product pipeline support.• Performed monocyte activation testing to detect pyrogenic potential of drug product impurities that helped to ensure product safety.• Used lentiviral transduction to overexpress the ACTH receptor in h-adrenal carcinoma cells to improve the magnitude and sensitivity of the cAMP response.• Successfully completed training and transfer of complex bioassay to CRO to meet project requirements.